Trade

with

Cardiome Pharma Corp
(NASDAQ: CRME)
AdChoices
8.30
-0.21
-2.47%
After Hours :
-
-
-

Open

8.49

Previous Close

8.51

Volume (Avg)

21.93k (86.94k)

Day's Range

8.30-8.59

52Wk Range

3.58-11.00

Market Cap.

140.59M

Dividend Rate ( Yield )

-

Beta

1.66

Shares Outstanding

16.52M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 4.51M

    • Net Income

    • 4.77M

    • Market Cap.

    • 140.59M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -92.95

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.66

    • Forward P/E

    • -25.97

    • Price/Sales

    • 6.20

    • Price/Book Value

    • 4.87

    • Price/Cash flow

    • -5.34

      • EBITDA

      • 5.61M

      • Return on Capital %

      • -50.60

      • Return on Equity %

      • -70.29

      • Return on Assets %

      • -50.60

      • Book Value/Share

      • 1.70

      • Shares Outstanding

      • 16.52M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 12.19

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -0.98

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 7,065.40

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 27.90

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 76.17

            • 82.75

            • Pre-Tax Margin

            • -91.03

            • 39.38

            • Net Profit Margin

            • -92.95

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 95.90

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -803.80

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 2.03

              • 2.92

              • Quick Ratio

              • 1.18

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.65

              • 2.21

              • Book Value/Share

              • 1.70

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -6.06

                • 217.39

                • P/E Ratio 5-Year High

                • -37.25

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.96

                • 124.82

                • Price/Sales Ratio

                • 5.69

                • 9.52

                • Price/Book Value

                • 4.47

                • 8.61

                • Price/Cash Flow Ratio

                • -5.34

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -70.29

                        (-12.60)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -50.60

                        (-4.50)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -70.29

                        (-4.20)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 1.01

                      • 1.48

                      • Asset Turnover

                      • 0.54

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -16.70M
                      Operating Margin
                      -370.14
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -5.34
                      Ownership

                      Institutional Ownership

                      57.28%

                      Top 10 Institutions

                      60.21%

                      Mutual Fund Ownership

                      12.68%

                      Float

                      85.73%

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® Value Fund

                      •  

                        1,013,700

                      • 0.00

                      • 6.13

                      • Fidelity Advisor® Capital Development

                      •  

                        257,537

                      • -5.36

                      • 1.56

                      • Fidelity® Large Cap Stock Fund

                      •  

                        240,645

                      • 0.00

                      • 1.45

                      • Fidelity Advisor® Large Cap Fund

                      •  

                        82,130

                      • 0.00

                      • 0.50

                      • Turner Medical Sciences Long/Short

                      •  

                        65,813

                      • 0.00

                      • 0.40

                      • Turner Spectrum Fund

                      •  

                        58,600

                      • 0.00

                      • 0.35

                      • Perkins Discovery Fund

                      •  

                        10,000

                      • -28.57

                      • 0.06

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • FMR LLC

                      •  

                        1,608,682

                      • -2.74%

                      • 9.74

                      • Adage Capital Partners Gp LLC

                      •  

                        1,132,260

                      • 0.00%

                      • 6.88

                      • Fortress Investment Group LLC

                      •  

                        981,596

                      • 0.00%

                      • 5.94

                      • Government Pension Fund of Norway - Global

                      •  

                        471,441

                      • +61.25%

                      • 0.77

                      • Westfield Capital Management Company, LP

                      •  

                        277,164

                      • -7.63%

                      • 1.68

                      • Alistair Capital Management, L.L.C.

                      •  

                        215,900

                      • -61.63%

                      • 1.31

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      Cardiome Pharma Corp was incorporated on December 12, 1986. The Company is a specialty pharmaceutical company engaged in the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It currently has two marketed, in-hospital, cardiology products, BRINAVESS, for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adultsand and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in Acute Coronary Syndrome patients. Both of its products are commercially available in numerous markets outside of the United States. BRINAVESS was approved in September 2010 and has been launched in the European Union, Iceland and Norway.

                      Key People

                      Dr. William L. Hunter M.D.,M.Sc.

                      CEO/Director/President

                      Mr. Robert W. Rieder

                      Chairman of the Board/Director

                      Ms. Jennifer Archibald

                      CFO

                      Dr. Harold H. Shlevin,PhD

                      Director

                      Dr. Richard M. Glickman,L.L.D.

                      Director

                      • Cardiome Pharma Corp

                      • 6190 Agronomy Road

                      • Vancouver, BC V6T 1Z3

                      • CAN.Map

                      • Phone: +1 604 677-6905

                      • Fax: +1 604 677-6915

                      • cardiome.com

                      Incorporated

                      1986

                      Employees

                      75

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: